{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:25:29Z","timestamp":1773275129266,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,5,7]],"date-time":"2009-05-07T00:00:00Z","timestamp":1241654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1038\/nrendo.2009.61","type":"journal-article","created":{"date-parts":[[2009,5,7]],"date-time":"2009-05-07T11:37:55Z","timestamp":1241696275000},"page":"312-318","source":"Crossref","is-referenced-by-count":14,"title":["Graves orbitopathy: a perspective"],"prefix":"10.1038","volume":"5","author":[{"given":"Petros","family":"Perros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerasimos E.","family":"Krassas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,5,7]]},"reference":[{"key":"BFnrendo200961_CR1","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/ncpendmet0497","volume":"3","author":"WM Wiersinga","year":"2007","unstructured":"Wiersinga, W. M. Management of Graves' ophthalmopathy. Nat. Clin. Pract. Endocrinol. Metab. 3, 396\u2013404 (2007).","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"BFnrendo200961_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1530\/EJE-07-0205","volume":"157","author":"I Coulter","year":"2007","unstructured":"Coulter, I.  et al. Psychological implications of Graves' orbitopathy. Eur. J. Endocrinol. 157, 127\u2013131 (2007).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo200961_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1210\/jcem-70-1-89","volume":"70","author":"M Salvi","year":"1990","unstructured":"Salvi, M.  et al. Patients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalities. J. Clin. Endocrinol. Metab. 70, 89\u201394 (1990).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo200961_CR4","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1089\/thy.2000.10.1093","volume":"10","author":"DH Khoo","year":"2000","unstructured":"Khoo, D. H.  et al. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels. Thyroid 10, 1093\u20131100 (2000).","journal-title":"Thyroid"},{"key":"BFnrendo200961_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000107447","volume-title":"Graves' Orbitopathy. A Multidisciplinary Approach","author":"J Orgiazzi","year":"2007","unstructured":"Orgiazzi, J. in Graves' Orbitopathy. A Multidisciplinary Approach (eds Wiersinga, W. M. & Kahaly, G. J.) 41\u201356 (Karger Publishers, Basel, 2007)."},{"key":"BFnrendo200961_CR6","first-page":"691","volume":"84","author":"P Perros","year":"1992","unstructured":"Perros, P. & Kendall-Taylor, P. Biological activity of autoantibodies from patients with thyroid-associated ophthalmopathy: in vitro effects on porcine extraocular myoblasts. Q. J. Med. 84, 691\u2013706 (1992).","journal-title":"Q. J. Med."},{"key":"BFnrendo200961_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/BF03347708","volume":"17","author":"P Perros","year":"1994","unstructured":"Perros, P. & Kendall-Taylor, P. Demonstration of thyrotropin binding sites in orbital connective tissue: possible role in the pathogenesis of thyroid-associated ophthalmopathy. J. Endocrinol. Invest. 17, 163\u2013170 (1994).","journal-title":"J. Endocrinol. Invest."},{"key":"BFnrendo200961_CR8","first-page":"2557","volume":"84","author":"RW Valyasevi","year":"1999","unstructured":"Valyasevi, R. W.  et al. Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor. J. Clin. Endocrinol. Metab. 84, 2557\u20132562 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo200961_CR9","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1046\/j.1365-2265.2003.01708.x","volume":"58","author":"IM Wakelkamp","year":"2003","unstructured":"Wakelkamp, I. M.  et al. TSH-R expression and cytokine profile in orbital tissue of active vs inactive Graves' ophthalmopathy patients. Clin. Endocrinol. (Oxf.) 58, 280\u2013287 (2003).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo200961_CR10","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1136\/bjo.2004.050807","volume":"89","author":"A Boschi","year":"2005","unstructured":"Boschi, A.  et al. Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy. Br. J. Ophthalmol. 89, 724\u2013729 (2005).","journal-title":"Br. J. Ophthalmol."},{"key":"BFnrendo200961_CR11","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1530\/eje.1.01900","volume":"152","author":"P Agretti","year":"2005","unstructured":"Agretti, P.  et al. Evidence for protein and mRNA TSHR expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after adipocytic differentiation. Eur. J. Endocrinol. 152, 777\u2013784 (2005).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo200961_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1046\/j.1365-2265.2000.00959.x","volume":"52","author":"MN Gerding","year":"2000","unstructured":"Gerding, M. N.  et al. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clin. Endocrinol. (Oxf.) 52, 267\u2013271 (2000).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo200961_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3109\/08916939309014643","volume":"16","author":"DR Weightman","year":"1993","unstructured":"Weightman, D. R.  et al. Autoantibodies to IGF-I binding sites in thyroid associated ophthalmopathy. Autoimmunity 16, 251\u2013257 (1993).","journal-title":"Autoimmunity"},{"key":"BFnrendo200961_CR14","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.4049\/jimmunol.178.5.3281","volume":"178","author":"RS Douglas","year":"2007","unstructured":"Douglas, R. S.  et al. Aberrant expression of the insulin-like growth factor-1 receptor by T cells from patients with Graves' disease may carry functional consequences for disease pathogenesis. J. Immunol. 178, 3281\u20133287 (2007).","journal-title":"J. Immunol."},{"key":"BFnrendo200961_CR15","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1089\/thy.2007.0404","volume":"18","author":"TJ Smith","year":"2008","unstructured":"Smith, T. J.  et al. Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy. Thyroid 18, 983\u2013988 (2008).","journal-title":"Thyroid"},{"key":"BFnrendo200961_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2265.2007.02854.x","volume":"67","author":"T Bednarczuk","year":"2007","unstructured":"Bednarczuk, T.  et al. Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack? Clin. Endocrinol. (Oxf.) 67, 3\u201319 (2007).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo200961_CR17","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1089\/thy.2007.0153","volume":"17","author":"EM Jacobson","year":"2007","unstructured":"Jacobson, E. M. & Tomer, Y. The genetic basis of thyroid autoimmunity. Thyroid 17, 949\u2013961 (2007).","journal-title":"Thyroid"},{"key":"BFnrendo200961_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1365-2265.1993.tb00516.x","volume":"38","author":"P Perros","year":"1993","unstructured":"Perros, P.  et al. Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid\u2013eye clinic. Clin. Endocrinol. (Oxf.) 38, 367\u2013372 (1993).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"Suppl. 3","key":"BFnrendo200961_CR19","first-page":"513","volume":"1","author":"WM Wiersinga","year":"2004","unstructured":"Wiersinga, W. M. Thyroid-associated ophthalmopathy: pediatric and endocrine aspects. Pediatr. Endocrinol. Rev. 1 (Suppl. 3), 513\u2013517 (2004).","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"BFnrendo200961_CR20","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1530\/eje.1.01991","volume":"153","author":"GE Krassas","year":"2005","unstructured":"Krassas, G. E.  et al. Childhood Graves' ophthalmopathy: results of a European questionnaire study. Eur. J. Endocrinol. 153, 515\u2013521 (2005).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo200961_CR21","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1530\/eje.1.02157","volume":"154","author":"GE Krassas","year":"2006","unstructured":"Krassas, G. E. & Wiersinga, W. Smoking and autoimmune thyroid disease: the plot thickens. Eur. J. Endocrinol. 154, 777\u2013780 (2006).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo200961_CR22","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1046\/j.1365-2265.1996.8220832.x","volume":"45","author":"J Pfeilschifter","year":"1996","unstructured":"Pfeilschifter, J. & Ziegler, R. Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption. Clin. Endocrinol. (Oxf.) 45, 477\u2013481 (1996).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo200961_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1210\/jc.2006-1824","volume":"92","author":"TJ Cawood","year":"2007","unstructured":"Cawood, T. J.  et al. Smoking and thyroid-associated ophthalmopathy: a novel explanation of the biological link. J. Clin. Endocrinol. Metab. 92, 59\u201364 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo200961_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1046\/j.1365-2265.2001.01349.x","volume":"55","author":"AJ Dickinson","year":"2001","unstructured":"Dickinson, A. J. & Perros, P. Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment. Clin. Endocrinol. (Oxf.) 55, 283\u2013303 (2001).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo200961_CR25","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1530\/eje.1.02230","volume":"155","author":"WM Wiersinga","year":"2006","unstructured":"Wiersinga, W. M.  et al. Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur. J. Endocrinol. 155, 387\u2013389 (2006).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo200961_CR26","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S0002-9394(14)72787-4","volume":"119","author":"GB Bartley","year":"1995","unstructured":"Bartley, G. B. & Gorman, C. A. Diagnostic criteria for Graves' ophthalmopathy. Am. J. Ophthalmol. 119, 792\u2013795 (1995).","journal-title":"Am. J. Ophthalmol."},{"key":"BFnrendo200961_CR27","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1136\/bjo.2006.094607","volume":"91","author":"D McKeag","year":"2007","unstructured":"McKeag, D.  et al. Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey. Br. J. Ophthalmol. 91, 455\u2013458 (2007).","journal-title":"Br. J. Ophthalmol."},{"key":"BFnrendo200961_CR28","first-page":"113","volume":"29","author":"IB Hales","year":"1960","unstructured":"Hales, I. B. & Rundle, F. F. Ocular changes in Graves' disease. A long-term follow-up study. Q. J. Med. 29, 113\u2013126 (1960).","journal-title":"Q. J. Med."},{"key":"BFnrendo200961_CR29","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.ophtha.2006.10.036","volume":"114","author":"L Baldeschi","year":"2007","unstructured":"Baldeschi, L.  et al. Reactivation of Graves' orbitopathy after rehabilitative orbital decompression. Ophthalmology 114, 1395\u20131402 (2007).","journal-title":"Ophthalmology"},{"key":"BFnrendo200961_CR30","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1530\/EJE-07-0666","volume":"58","author":"L Bartalena","year":"2008","unstructured":"Bartalena, L.  et al. Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy. Eur. J. Endocrinol. 58, 273\u2013285 (2008).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo200961_CR31","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1089\/105072502753600214","volume":"12","author":"P Perros","year":"2002","unstructured":"Perros, P. & Kendall-Taylor, P. Medical treatment for thyroid-associated ophthalmopathy. Thyroid 12, 241\u2013244 (2002).","journal-title":"Thyroid"},{"key":"BFnrendo200961_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1056\/NEJM199801083380201","volume":"338","author":"L Bartalena","year":"1998","unstructured":"Bartalena, L.  et al. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N. Engl. J. Med. 338, 73\u201378 (1998).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo200961_CR33","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1056\/NEJM199206253262603","volume":"326","author":"L Tallstedt","year":"1992","unstructured":"Tallstedt, L.  et al. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. N. Engl. J. Med. 326, 1733\u20131738 (1992).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo200961_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1530\/eje.1.01938","volume":"153","author":"L Bartalena","year":"2005","unstructured":"Bartalena, L.  et al. Glucocorticoids and outcome of radioactive iodine therapy for Graves' hyperthyroidism. Eur. J. Endocrinol. 153, 13\u201314 (2005).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo200961_CR35","doi-asserted-by":"publisher","first-page":"5321","DOI":"10.1210\/jc.2005-0507","volume":"90","author":"P Perros","year":"2005","unstructured":"Perros, P.  et al. A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active Graves' ophthalmopathy. J. Clin. Endocrinol. Metab. 90, 5321\u20135323 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo200961_CR36","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1089\/thy.2005.15.1157","volume":"15","author":"J J\u00e4rhult","year":"2005","unstructured":"J\u00e4rhult, J.  et al. Graves' disease with moderate\u2013severe endocrine ophthalmopathy\u2014long-term results of a prospective, randomized study of total or subtotal thyroid resection. Thyroid 15, 1157\u20131164 (2005).","journal-title":"Thyroid"},{"key":"BFnrendo200961_CR37","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1210\/jc.2006-1800","volume":"92","author":"F Menconi","year":"2007","unstructured":"Menconi, F.  et al. Effects of total thyroid ablation versus near-total thyroidectomy alone on mild to moderate Graves' orbitopathy treated with intravenous glucocorticoids. J. Clin. Endocrinol. Metab. 92, 1653\u20131658 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo200961_CR38","first-page":"223","volume":"28","author":"RH Hart","year":"2003","unstructured":"Hart, R. H. & Perros, P. Glucocorticoids in the medical management of Graves' ophthalmopathy. Minerva Endocrinol. 28, 223\u2013231 (2003).","journal-title":"Minerva Endocrinol."},{"key":"BFnrendo200961_CR39","doi-asserted-by":"publisher","first-page":"5234","DOI":"10.1210\/jc.2005-0148","volume":"90","author":"GJ Kahaly","year":"2005","unstructured":"Kahaly, G. J.  et al. Randomized, single-blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy. J. Clin. Endocrinol. Metab. 90, 5234\u20135240 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo200961_CR40","first-page":"3562","volume":"86","author":"C Marcocci","year":"2001","unstructured":"Marcocci, C.  et al. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study. J. Clin. Endocrinol. Metab. 86, 3562\u20133567 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo200961_CR41","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1089\/jop.2005.21.328","volume":"21","author":"RH Hart","year":"2005","unstructured":"Hart, R. H.  et al. Early response to intravenous glucocorticoids for severe thyroid-associated ophthalmopathy predicts treatment outcome. J. Ocul. Pharmacol. Ther. 21, 328\u2013336 (2005).","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"BFnrendo200961_CR42","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1089\/thy.2006.0267","volume":"17","author":"R Le Moli","year":"2007","unstructured":"Le Moli, R.  et al. Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in Graves' ophthalmopathy. Thyroid 17, 357\u2013362 (2007).","journal-title":"Thyroid"},{"key":"BFnrendo200961_CR43","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1530\/eje.1.02201","volume":"155","author":"P Perros","year":"2006","unstructured":"Perros, P.  et al. A questionnaire survey on the management of Graves' orbitopathy in Europe. Eur. J. Endocrinol. 155, 207\u2013211 (2006).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo200961_CR44","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/j.1365-2265.2008.03289.x","volume":"69","author":"HE Ramos","year":"2008","unstructured":"Ramos, H. E.  et al. Management of Graves' orbitopathy in Latin America: an international questionnaire study compared with Europe. Clin. Endocrinol. (Oxf.) 69, 951\u2013956 (2008).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo200961_CR45","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.ophtha.2007.10.028","volume":"115","author":"EA Bradley","year":"2008","unstructured":"Bradley, E. A.  et al. Orbital radiation for Graves ophthalmopathy: a report by the American Academy of Ophthalmology. Ophthalmology 115, 398\u2013409 (2008).","journal-title":"Ophthalmology"},{"key":"BFnrendo200961_CR46","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2265.2005.02345.x","volume":"63","author":"IM Wakelkamp","year":"2005","unstructured":"Wakelkamp, I. M.  et al. Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial. Clin. Endocrinol. (Oxf.) 63, 323\u2013328 (2005).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo200961_CR47","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/S0140-6736(00)02165-6","volume":"355","author":"MP Mourits","year":"2000","unstructured":"Mourits, M. P.  et al. Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study. Lancet 355, 1505\u20131509 (2000).","journal-title":"Lancet"},{"key":"BFnrendo200961_CR48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1210\/jc.2003-030809","volume":"89","author":"MF Prummel","year":"2004","unstructured":"Prummel, M. F.  et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy. J. Clin. Endocrinol. Metab. 89, 15\u201320 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo200961_CR49","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000107475","volume-title":"Graves' Orbitopathy. A Multidisciplinary Approach","author":"L Baldeschi","year":"2007","unstructured":"Baldeschi, L. in Graves' Orbitopathy. A Multidisciplinary Approach (eds Wiersinga, W. M. & Kahaly, G. J.) 160\u2013175 (Karger Publishers, Basel, 2007)."},{"key":"BFnrendo200961_CR50","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1159\/000107478","volume-title":"Graves' Orbitopathy. A Multidisciplinary Approach","author":"C Neoh","year":"2007","unstructured":"Neoh, C. & Eckstein, A. in Graves' Orbitopathy. A Multidisciplinary Approach, (eds Wiersinga, W. M. & Kahaly, G. J) 188\u2013200 (Karger Publishers, Basel, 2007)."},{"key":"BFnrendo200961_CR51","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1177\/112067210401400401","volume":"14","author":"FE Finamor","year":"2004","unstructured":"Finamor, F. E.  et al. Pentoxifylline (PTX)-\u2014an alternative treatment in Graves' ophthalmopathy (inactive phase): assessment by a disease-specific quality of life questionnaire and by exophthalmometry in a prospective randomized trial. Eur. J. Ophthalmol. 14, 277\u2013283 (2004).","journal-title":"Eur. J. Ophthalmol."},{"key":"BFnrendo200961_CR52","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/BF03345280","volume":"27","author":"L Bartalena","year":"2004","unstructured":"Bartalena, L.  et al. Graves' ophthalmopathy: state of the art and perspectives. J. Endocrinol. Invest. 27, 295\u2013301 (2004).","journal-title":"J. Endocrinol. Invest."},{"key":"BFnrendo200961_CR53","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S0002-9394(00)00359-7","volume":"129","author":"EA Bouzas","year":"2000","unstructured":"Bouzas, E. A.  et al. Antioxidant agents in the treatment of Graves' ophthalmopathy. Am. J. Ophthalmol. 129, 618\u2013622 (2000).","journal-title":"Am. J. Ophthalmol."},{"key":"BFnrendo200961_CR54","doi-asserted-by":"publisher","first-page":"5910","DOI":"10.1210\/jc.2004-0697","volume":"89","author":"AJ Dickinson","year":"2004","unstructured":"Dickinson, A. J.  et al. Double-blind, placebo-controlled trial of octreotide long-acting repeatable (LAR) in thyroid-associated ophthalmopathy. J. Clin. Endocrinol. Metab. 89, 5910\u20135915 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo200961_CR55","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1210\/jc.2004-1334","volume":"90","author":"JL W\u00e9meau","year":"2005","unstructured":"W\u00e9meau, J. L.  et al. Octreotide (long-acting release formulation) treatment in patients with Graves' orbitopathy: clinical results of a four-month, randomized, placebo-controlled, double-blind study. J. Clin. Endocrinol. Metab. 90, 841\u2013848 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo200961_CR56","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/BF03344124","volume":"29","author":"TC Chang","year":"2006","unstructured":"Chang, T. C. & Liao, S. L. Slow-release lanreotide in Graves' ophthalmopathy: a double-blind randomized, placebo-controlled clinical trial. J. Endocrinol. Invest. 29, 413\u2013422 (2006).","journal-title":"J. Endocrinol. Invest."},{"key":"BFnrendo200961_CR57","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.1210\/jc.2006-1105","volume":"91","author":"MN Stan","year":"2006","unstructured":"Stan, M. N.  et al. Randomized, double-blind, placebo-controlled trial of long-acting release octreotide for treatment of Graves' ophthalmopathy. J. Clin. Endocrinol. Metab. 91, 4817\u20134824 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo200961_CR58","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1089\/thy.2006.16.709","volume":"16","author":"D El Fassi","year":"2006","unstructured":"El Fassi, D.  et al. Treatment-resistant severe, active Graves' ophthalmopathy successfully treated with B lymphocyte depletion. Thyroid 16, 709\u2013710 (2006).","journal-title":"Thyroid"},{"key":"BFnrendo200961_CR59","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1530\/eje.1.02325","volume":"156","author":"M Salvi","year":"2007","unstructured":"Salvi, M.  et al. Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study. Eur. J. Endocrinol. 156, 33\u201340 (2007).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo200961_CR60","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1517\/14712598.7.7.1061","volume":"7","author":"CH Nielsen","year":"2007","unstructured":"Nielsen, C. H.  et al. B-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy: the latest addition to an expanding family. Expert Opin. Biol. Ther. 7, 1061\u20131078 (2007).","journal-title":"Expert Opin. Biol. Ther."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2009.61.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2009.61","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nrendo.2009.61","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2009.61.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:33:18Z","timestamp":1684467198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrendo.2009.61"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,7]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["BFnrendo200961"],"URL":"https:\/\/doi.org\/10.1038\/nrendo.2009.61","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,7]]}}}